LionBird
VC Fund
Tel Aviv, Israel
LionBird is a Tel Aviv- and Chicago-based venture capital firm investing in early-stage software companies operating in the healthcare, commerce, and enterprise sectors. Founded in 2012, LionBird has developed an investment strategy around early-stage startups that leverages online technology to re-imagine traditional offline business processes andmodels.
- Total investments:
- 74
- Last investment:
- Lead investor:
- 28%
- Fund size:
- $85M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries LionBird invests in
Health CareSoftwareArtificial IntelligenceWellnessInformation Technology
Stages LionBird invests in
SeedSeries ASeries BSeries CFunding Round
Countries LionBird invests in
United StatesIsraelIndia
Round sizes
Seed $1.3M–$17MSeries A $3.5M–$19MSeries B $6.5M–$40M
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.3M–$17M
- Series A
- $3.5M–$19M
- Series B
- $6.5M–$40M
Investment Focus
Industry
- Health Care 19 (26%)
- Software 15 (20%)
- Artificial Intelligence 12 (16%)
- Wellness 5 (7%)
- Information Technology 5 (7%)
Stage
- Seed 27 (36%)
- Series A 17 (23%)
- Series B 11 (15%)
- Series C 5 (7%)
- Funding Round 2 (3%)
Country
- United States 34 (46%)
- Israel 5 (7%)
- India 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Chaim Friedman
Founding Partner
|
Founding Partner | Total investments: 0 | Find email | |
Ed Michael
Managing Partner
|
Managing Partner | Total investments: 3 | Find email | |
Eric Fenster
Solo Legal Counsel / Partner
|
Solo Legal Counsel / Partner | Total investments: 0 | Find email | |
Gal Noyman Veksler
Principal
|
Principal | Total investments: 3 | Find email | |
Itschak Friedman
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Jimini Health
|
Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients. | $17M / Seed / Mar 31, 2026 | |
Rhino Federated Computing
|
Rhino Federated Computing solves one of the biggest challenges in AI: seamlessly connecting siloed data through federated computing. The Rhino Federated Computing Platform (RhinoFCP) serves as the ‘data collaboration tech stack’, extending from providing computing resources to data preparation & discoverability, to model development &monitoring — all in a secure, privacy-preserving environment. To do this, Rhino FCP offers flexible architecture (multi-cloud and on-prem hardware), end-to-end data management workflows (multimodal data, schema definition, harmonization, and visualization), privacy enhancing technologies (e.g., differential privacy), and allows for the secure deployment of custom code & 3rd party applications via persistent data pipelines. Rhino is trusted by >60 leading organizations worldwide — including 14 of 20 of Newsweek’s ‘Best Smart Hospitals’ and top 20 global biopharma companies — and is leveraging this foundation for financial services, ecommerce, and beyond. The company is headquartered in Boston, with an R&D center in Tel Aviv. | $15M / Series A / May 22, 2025 | |
PhaseV
|
PhaseV is creating tools and cutting-edge statistical approaches to transform trial design, execution, and analysis. PhaseV recognizes hidden signals in clinical data and extracts actionable insights to help determine the best next moves. The company's technology provides optimal adaptive clinical trial design and closed-loop execution,enhancing efficiency and success rates. PhaseV is developing clinical trial paradigm shifts in order to provide novel therapies to more people in a more precise and efficient manner. | $50M / Series A / May 13, 2025 | |
Phantom Neuro
|
Phantom Neuro develops innovative muscle-machine interfaces that enhance robotic limb rehabilitation. The company focuses on creating solutions that improve mobility for users by integrating neurotechnology with robotic systems. Through its minimally invasive approach, Phantom Neuro aims to facilitate precise control of robotic limbs, allowing formore natural movement and better user experiences. The company is committed to advancing the field of neurotechnology, providing valuable tools for rehabilitation and improving the quality of life for individuals with mobility challenges. Phantom Neuro also explores various applications of its technologies, contributing to the broader field of assistive robotics. | $19M / Series A / Apr 15, 2025 | |
|
Phantom Neuro
|
Phantom Neuro develops innovative muscle-machine interfaces that enhance robotic limb rehabilitation. The company focuses on creating solutions that improve mobility for users by integrating neurotechnology with robotic systems. Through its minimally invasive approach, Phantom Neuro aims to facilitate precise control of robotic limbs, allowing formore natural movement and better user experiences. The company is committed to advancing the field of neurotechnology, providing valuable tools for rehabilitation and improving the quality of life for individuals with mobility challenges. Phantom Neuro also explores various applications of its technologies, contributing to the broader field of assistive robotics. | $19M / Series A / Apr 15, 2025 | |
|
Jimini Health
|
Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients. | $8M / Pre-Seed / Nov 19, 2024 | |
OneStep
|
OneStep is a digital health platform that provides clinically-validated feedback to clients. OneStep was headquartered in Tel Aviv, Israel. | $36M / Series B / Oct 22, 2024 | |
PatientPartner
|
PatientPartner is creating the first ever defined patient journey. A roadmap to every patient’s healthcare experience that provides a simple step by step process for navigating through any treatment, any procedure, or any condition. By combining artificial intelligence and machine learning with personalized human connections, we are able to createrelatable experiences between patients, providers and industry partners all in once place. Our vision is to create a platform where the world comes to understand their health. A future where all of healthcare can be found on a single platform that is focused on ensuring patients get the care and experiences they deserve. We work with physicians, healthcare institutions and medical technology companies across all healthcare verticals to bring new motivated patients into their clinics, reduce patient drop off, and collect long-term patient outcome data to better identify future patient needs and create better experiences. | $3.5M / Seed / Sep 04, 2024 | |
Heyday Health
|
Heyday Health offers primary care for adults providing in-home and video visits, clinical team, and continuous accessibility. | $12.5M / Venture - Series Unknown / Jun 24, 2024 | |
Black Ore Technologies
|
Black Ore Technologies is a technology-driven company currently operating in stealth mode. The company's flagship platform, Tax Autopilot, offers end-to-end 1040 tax prep automation for CPAs and tax firms | $60M / Seed / Nov 07, 2023 | |
| See all 74 investments → | |||
Co-Investors
Kaiser Permanente Ventures
8 deals together
Arkin Digital Health
7 deals together
Blumberg Capital
7 deals together
Easton Capital
6 deals together
New Leaf Venture Partners
6 deals together
Arthur Ventures
4 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Artificial intelligence Investors
40,702 investors
Wellness Investors
11,737 investors
SaaS VC Funds
61,208 investors
Enterprise VC Funds
49,693 investors
Software VC Funds
31,919 investors
FAQ
What does LionBird invest in?
LionBird invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 74 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is LionBird's check size?
LionBird typically joins rounds of $1.3M–$17M at Seed, $3.5M–$19M at Series A and $6.5M–$40M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds LionBird participates in.
How do I contact LionBird?
Public channels for LionBird include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at LionBird?
The team at LionBird includes Chaim Friedman (Founding Partner), Ed Michael (Managing Partner) and Eric Fenster (Solo Legal Counsel / Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
